Skip to main content
Nutrition Reviews logoLink to Nutrition Reviews
. 2025 Jun 27;84(2):379–394. doi: 10.1093/nutrit/nuae190

The Impacts of Probiotics Supplementation on the Treatment of Periodontitis: An Umbrella Meta-Analysis

Junfeng Tan 1,#, Dan Zhang 2,#, Li Cheng 3,#, Ning Liu 4, Mehrdad Jamali 5,6, Helen Jamloo 7, Rosana Farjaminejad 8, Changjiang Lei 9,✉, Ahmad Saedisomeolia 10,11, Abdolreza Jamilian 12,13,✉
PMCID: PMC12793512  PMID: 40576216

Abstract

Context

Probiotics supplementation has many beneficial impacts on periodontitis outcomes.

Objective

This umbrella meta-analysis evaluated the effectiveness of probiotics in treating periodontitis, focusing on primary outcome measures, including reductions in probing pocket depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), plaque index (PI), gingival index (GI), and PDD reduction in medium and deep pockets.

Data Source

The Scopus, PubMed, Web of Science, Embase, and Google Scholar online databases were searched up to January 2024.

Data Extraction

All meta-analyses evaluating the impact of probiotics supplementation on periodontitis outcomes were considered eligible.

Data Analysis

A random-effects model was employed to estimate the pooled results. Subgroup and sensitivity analyses were conducted. The quality of the studies was evaluated using the AMSTAR2 tool. Overall, 19 meta-analyses with 67 data sets were included in this umbrella review. Our findings indicated that probiotics supplementation significantly decreased BOP (effect size [ES]: −8.20; 95% CI: −15.10 to −1.31; P = .02) and CAL after sensitivity analysis (ES: −0.52; 95% CI: −0.75 to −0.28; P < .05). No other significant effect was observed on PPD, PI, GI, or PDD reduction in medium and deep pockets.

Conclusion

This umbrella meta-analysis found that, during their treatment process, probiotics supplementation may positively affect BOP and CAL in people with periodontitis.

Keywords: probiotics, periodontitis, oral flora, umbrella meta-analysis

INTRODUCTION

Periodontal disease is a chronic inflammatory condition that affects the periodontium, including the gingiva, periodontal ligament, alveolar bone, and cementum. The onset of this disease is initiated by the presence of periodontopathogens within the dental plaque biofilm that accumulates on tooth surfaces close to the gingiva.1–3 Gingivitis is identified as the initial stage and least severe manifestation of periodontal disease.4 Gingivitis is a condition that can be reversed, but if left untreated, it can evolve to periodontitis, which represents the more severe stage of periodontal disease.4–6 The presence of redness, swelling, mild irritation, inflammation of the gingival tissue, and moderate bleeding with brushing or flossing distinguishes gingivitis. In contrast, periodontitis is defined by inflammation and the deterioration of alveolar bone and connective tissue between the gingiva and tooth root.3,7 It is estimated that approximately 19% of the adult population worldwide is affected by severe periodontal diseases, amounting to over 1 billion cases.8 Periodontal disease results from a combination of modifiable and nonmodifiable factors. Modifiable risk factors encompass behaviors that can be altered, such as smoking, having an unhealthy diet characterized by high levels of sugars and saturated fats, inadequate oral hygiene practices, heightened stress levels, and the intake of certain medications. On the other hand, nonmodifiable risk factors include age, sex, and genetic predisposition.9 The primary cause of periodontal disease is an imbalanced population of bacteria in the area below the gum line, which gradually develops over time. This imbalance is characterized by an increasing prevalence of periodontal disease and a corresponding decrease in bacteria associated with oral health. As a result, the average balance between the microbiota and the host is disrupted, leading to the onset of periodontal disease.10–14 The aforementioned progressive process commences with the initial adhesion, proliferation, and colonization of gram-negative and gram-positive bacteria on the tooth’s surface, with subsequent extension into the subgingival region.15 Under these circumstances, certain pathogenic bacteria, namely Prevotella intermedia, Parvimonas micra, Fusobacterium nucleatum (F. nucleatum), Porphyromonas gingivalis, Tanerella forsythia, and Treponema denticola, possess the capability to thrive and establish colonies. By releasing bacterial collagens, these bacteria induce a pro-inflammatory response and damage the surrounding tissues.2,3,11 Periodontal therapy involves the removal of supra- and subgingival plaque from tooth surfaces using subgingival instrumentation.16 In order to enhance illness outcomes, the integration of surgical site infection prevention measures into surgical procedures or the administration of supplementary antibiotics can be considered.16–18 However, the administration of antibiotics can result in unfavorable side effects or may be prohibited under some circumstances. Consequently, it becomes imperative to explore other methods.

Probiotics are live organisms (typically bacteria) offered to provide health advantages in the prevention or therapeutic management of certain diseases.19,20 Probiotics have been long regarded in the medical field as an adjuvant treatment for gastrointestinal diseases.21 Moreover, probiotics are indicated for individuals who use antibiotics for the prevention and treatment of Antibiotic-Associated Diarrhea. They have also been examined in the clinical care of various illnesses, including respiratory tract infections.19–23 In addition, probiotics may have a therapeutic benefit in dental caries prevention by decreasing the number of cariogenic bacteria, such as Streptococcus mutants.24 Probiotics may work through many methods, including the formation of antimicrobial metabolites, immunomodulation, mucosal barrier enhancement, and microbial flora shift through competition for cell adhesion with pathogenic strains.25,26 Also, probiotics play a significant role in managing periodontal diseases by modulating the immune response. They increase the levels of anti-inflammatory cytokines, while decreasing pro-inflammatory cytokines. For example, research by Teughels et al27 showed that Lactobacillus reuteri boosts interleukin 10 (IL-10) in gingival fluid, promoting an anti-inflammatory environment beneficial for periodontal health. Similarly, Gupta28 reported that various probiotic strains could downregulate TNF-alpha, a key factor in the inflammatory cascade leading to periodontal tissue destruction. Several systematic review and meta-analysis studies have been conducted addressing the effect of probiotics on treatment outcomes, but their results are contradictory, and most meta-analyses have not been able to evaluate the benefits and detailed evaluation of the effect of probiotics due to the limited number of included studies. For example, Akram et al conducted a study that did not observe any enhancement in plaque index (PI) or gingival index (GI) among patients with gingivitis following the administration of probiotics. Conversely, some literature evaluations have reached the conclusion that probiotics may have the potential to ameliorate PI and GI.29–31 Therefore, the aim of conducting the current umbrella meta-analysis was to combine the results of past meta-analyses and to examine more precisely and comprehensively the effects of probiotics on therapeutic outcomes such as PI, gingival index (GI), probing pocket depth (PPD), clinical attachment level (CAL), and bleeding on probing (BOP).

METHODS

Search Strategy and Study Selection

This investigation was executed according to the standards of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) to ensure a systematic and rigorous methodology.32 An extensive search was performed by 2 reviewers (M.J., M.Z.) in significant international scientific databases, notably PubMed, Scopus, and Web of Science, to locate articles of interest. The search includes all articles available in each database from its establishment up to January 2024. The search strategy was built based on relevant keywords as follows: (((TITLE-ABS-KEY (probiotics) OR TITLE-ABS-KEY (“prebiotics”) OR TITLE-ABS-KEY (“synbiotics”))) AND ((TITLE-ABS-KEY (“periodontitis”) OR TITLE-ABS-KEY (“periodontal disease”) OR TITLE-ABS-KEY (“gum disease”) OR TITLE-ABS-KEY (“gum infection”))) AND ((TITLE-ABS-KEY (meta) OR TITLE-ABS-KEY (meta-analysis)))). Moreover, our search was restricted to articles published in the English language only. The application of the wild-card term “*” was employed to improve the sensitivity of the search strategy.

Inclusion and Exclusion Criteria

The PICOS criteria for this umbrella meta-analysis were as follows: Population (P: Patients or healthy adults with periodontitis), Intervention (I: Probiotics), Comparison (C: Control group), Outcome (O: Periodontitis parameters including PI, and GI, PPD, CAL, BOP, PDD reduction in moderate and deep pockets), Study design (S: Umbrella meta-analysis). Additionally, studies conducted in vitro, in vivo, and ex vivo, as well as case reports, quasi-experimental studies, and observational studies were excluded.

Methodological Quality Assessment and Data Extraction

Two independent reviewers (M.J., R.F.) assessed the methodological quality of the included articles using the Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR2) questionnaire.33 If any discrepancies arose, the senior author (A.B.) was consulted to achieve a consensus. The AMSTAR2 questionnaire comprises 16 items that are answered with “Yes,” “Partial Yes,” “No,” or “Not a Meta-analysis.” The AMSTAR2 checklist is divided into 4 categories: “Critically low quality,” “Low quality,” “Moderate quality,” and “High quality.” A score of 7 or higher indicated that a meta-analysis was of high quality. The purpose of this tool is to comprehensively review studies, including protocol registration review, PICO elements, literature search, study selection and data extraction, risk of bias in individual studies, funding sources, appropriate methods for statistical pooling, assessment of publication bias, and conflict of interest. By examining the above, the quality of a study can be determined well. Two reviewers independently (M.J., R.F.) also extracted the following data from the included meta-analyses: year of publication, sample size, study location, type of probiotics, mean dose of the study included in the meta-analysis, mean duration of the study included in the meta-analysis, effect sizes (ESs) including weighted mean difference (WMD), standardized mean difference (SMD), and corresponding CIs, which were subsequently recorded in an Excel spreadsheet. Also, discrepancies were resolved through consultation and coordination with the third author.

Data Synthesis and Statistical Analysis

A random-effects model using the restricted maximum likelihood method (REML)34 was employed to estimate the pooled ES and its corresponding 95% CI. To assess heterogeneity, the I2 statistic and Cochrane’s Q-test were utilized. Heterogeneity was considered substantial if the I2 value exceeded 50% or if the P-value for the Q-test was <.1. Subgroup analyses were conducted based on predefined variables, such as the treatment duration, sample size, and number of included studies. Also, the results of subgroup analysis were used if necessary to find the source of heterogeneity. A sensitivity analysis was performed to evaluate the impact of an individual study’s removal on the overall effect size. The sensitivity analysis included various steps: (1) each study included in the meta-analysis was removed one by one to see the effect of its removal on the overall results, (2) recalculation of the meta-analysis, (3) documentation of changes, and (4) reporting in the manuscript. Begg’s and Egger’s tests35,36 and a visual inspection of the funnel plot were performed to assess publication bias. If publication bias was obvious, trim and fill methods were followed. All statistical analyses were conducted using Stata version 16 (Stata Corporation, College Station, TX, US), and a P-value of less than .05 was considered statistically significant.

RESULTS

Literature Review

First, we retrieved 100 articles by searching the databases. Second, 50 studies relevant to probiotics’ effect on periodontal outcome remained after deduplication. After evaluating the titles and abstracts, 30 articles were excluded. Three studies were also excluded after full-text screening. The selection process and reasons for exclusion are presented in a flow diagram (Figure 1)—finally, 17 studies with 65 datasets were regarded as eligible for the umbrella review.

Figure 1.

Figure 1.

Flow Diagram of Study Selection

Characteristics of the Included Meta-Analyses

The characteristics of 17 meta-analyses that were included in our study are presented in Table 1.37–54 Among them 7 articles were conducted in China,37,40,41,46–49 1 in the UK,50 1 in Sweden,38 1 in Singapore,39 1 in Lebanon,42 1 in Canada,43 1 in India,45 1 in Brazil,51 1 in Pakistan,52 1 in Germany,54 and 1 in France.53 All of the included studies were meta-analyses of RCTs published between 2016 and 2023. Thirteen studies, each consisting of 24 datasets, have been conducted to assess the effects of probiotics on PDD.37–39,42,43,45–50,53,54 A total of 7 scholarly articles have investigated the impact of probiotic supplements on BOP.37,40,42,43,46,53,54 A total of 10 scholarly studies, encompassing 14 distinct datasets, have examined changes in CAL as a dependent variable in response to the administration of probiotics.37,42,43,45,46,48,49,52–54 A total of 8 publications have examined the phenomenon of PI.37,40–43,47,51,54 Additionally, 4 articles have focused on GI, 37,40,43,54 while another 4 articles have investigated the outcomes of PDD reduction in both deep-pocket and moderate-pocket scenarios.37,46,50,53

Table 1.

Study Characteristics of Included Studies

First author Year Study type Gender Health status Age Dose (CFUa108) Duration (week) Outcomes Study-Number
J. Li 2023 RCT Both Healthy adults with periodontitis 43.7 3 24 PPD, BOP, CAL, PI, GI, PPD reduction in moderate pocket, PPD reduction in deep pocket 19
S. Sayardoust 2022 RCTs and cross-over Both Human subjects with oral implants replacing missing teeth (non-surgical treatment of peri-implant mucositis and peri-implantitis) 61.2 3 4 PPD 4
L. Hardan 2022 RCT NR Chronic periodontitis 42.55 NR 13.62 PPD, BOP, CAL, PI 21
Z. Gheisary 2022 RCT NR Adults with periodontal disease >18 NR NR PPD, BOP, CAL, PI, GI 64
S. Mishra 2022 RCT Both Chronic periodontitis 45.33 NR 3 (a), 12 (b), 24 (c), 48 (d) PPD 14
24 CAL
N. Huang 2022 RCT and crossover NR Patients diagnosed with halitosis 37.14 20.5 7.42 PI 7
N. Ethan 2021 RCT NR Healthy adults with periodontitis 49.5 8.94 12 (a), 24 (b), 48 (c) PPD 8
R. Zhao 2021 RCT Both Adults with periodontal disease 56.9 NR 16 PPD, PI 4
D. Hu 2021 RCT NR Patients with periodontal disease 46 NR Short-term PPD (a) 24
12 PPD (b), BOP, CAL, PPD reduction in moderate pocket, PPD reduction in deep pocket 24
D. Song 2020 RCT Both Chronic periodontitis 44.15 NR 3 PPD 8
12 (a), 24 (b) PPD, CAL
S.N.Ho (a) 2020 RCT NR Adults with periodontal disease 42.69 3.89 12 (a), 24 (b), 36 (c), 48 (d) PPD, CAL 11
N. Donos 2020 RCT Both Chronic periodontitis 46 0.68 3–12 PPD 5
10.5 PPD reduction in moderate pocket, PPD reduction in deep pocket
J. Liu 2020 RCT Both Plaque-induced gingivitis patients NR 8.8 4.9 BOP, PI, GI 11
S. Ikram 2018 RCT Both Chronic periodontitis 43.5 NR 20.14 CAL 7
P. Nadelman 2018 RCT NR Adults and children using dairy products containing probiotics 20.25 NR 7.7 PI 32
R. Martin-Cabezas 2016 RCT Both Chronic periodontitis 43.87 NR exactly 12 PPD 4
5.25 BOP, CAL, PPD reduction in moderate pocket, PPD reduction in deep pocket
D. Gruner (a) 2016 RCT NR Children and adults Children (<18) and adults (41.5) 126 NR PPD 50
RCT and cross-over 8 BOP, CAL, PI, GI

Abbreviations: BOP, bleeding on probing; CAL, clinical attachment level; CFUa, colony forming units; GI, gingival index; NR, not reported; PI, plaque index; PPD, probing pocket depth; RCT, randomized controlledtrial. 

Methodological Quality Assessment

Table 2 presents the findings of the quality assessment of the meta-analyses according to the AMSTAR2 questionnaire. Eight studies obtained a low ranking in terms of quality,37,42,45–49,51 2 studies were of moderate quality,39,41 while 9 studies were of high quality.38,40,43,50,53,54

Table 2.

Results of Assessment of the Methodological Quality of the Meta-Analyses

First author Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Overall
D. Hu Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes No Yes Yes Yes Low
D. Song Yes Partial Yes Yes Partial Yes No Yes Partial Yes Partial Yes Yes No Yes Yes Yes Yes No Yes Low
N. Donos Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes High
Gheisary Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes Yes Yes High
Gruner Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes Yes Yes High
Hardan Yes Yes Yes Partial Yes Yes No Yes Yes Yes No Yes Yes Yes No No Yes Low
Huang Yes Yes Yes Partial Yes Yes No Yes Yes Yes No Yes Yes Yes Yes Yes Yes Moderate
Ikram Yes Yes Yes Partial Yes Yes Yes Partial Yes Yes Yes No Yes Yes Yes Yes Yes Yes High
J. Li Yes Yes Yes Partial Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes No Yes Low
Liu Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes Yes Yes High
Martin-Cabezas Yes Yes Yes Partial Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes High
Mishra Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes No Yes Low
Nadelman Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes No Yes Low
Ethan Yes Yes Yes Partial Yes Yes No Yes Yes Yes No Yes Yes Yes Yes Yes Yes Moderate
S.N. Ho Yes Yes Yes Partial Yes No Yes Yes Yes Yes No Yes Yes Yes Yes No Yes Low
Sayardoust Yes Partial Yes Yes Partial Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes High
Zhao Yes Yes Yes Partial Yes Yes Yes Yes Partial Yes Yes No Yes Yes Yes Yes No Yes Low

Q1: Did the research questions and inclusion criteria for the review include the components of PICO? Q2: Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review, and did the report justify any significant deviations from the protocol? Q3: Did the review authors explain their selection of the study designs for inclusion in the review? Q4: Did the review authors use a comprehensive literature search strategy? Q5: Did the review authors perform the study selection in duplicate? Q6: Did the review authors perform data extraction in duplicate? Q7: Did the review authors provide a list of excluded studies and justify the exclusions? Q8: Did the review authors describe the included studies in adequate detail? Q9: Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? 10: Did the review authors report on the sources of funding for the studies included in the review? Q11: If a meta-analysis was performed, did the review authors use appropriate methods for the statistical combination of results? Q12: If a meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? Q13- Did the review authors account for RoB in individual studies when interpreting/discussing the review results? Q14: Did the review authors provide a satisfactory explanation for and discussion of any heterogeneity observed in the review results? Q15: If they performed quantitative synthesis, did the review authors conduct an adequate investigation of publication bias (small-study bias) and discuss its likely impact on the review results? Q16: Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?

Effect of Probiotics on Probing Pocket Depth

Based on the analysis conducted by ESs, integrating data from 11 studies with 24 datasets revealed a lack of a significant impact of probiotics on PPD (ES: −0.03; 95% CI: −0.22 to 0.16; P = .77) (Figure 2A). Moreover, a notable level of heterogeneity was observed among the studies (I2 = 97.1%, P-heterogeneity <.001). Subgroup analyses were performed to find the sources of heterogeneity, but no sources were found. No statistically significant difference was observed upon excluding a single study during the sensitivity analysis. Also, subgroup analyses based on the number of included studies and sample size did not show significant results. No significant results were obtained using other categories of intervention duration. A significant small-study effect was detected using Egger’s (P = .03), unlike Begg’s (P = .47) tests. Visual inspection of the funnel plot revealed an uneven distribution of meta-analyses; thus, a trim-and-fill analysis was performed, and the results still did not show significant effects (ES: −0.03; 95% CI: −0.24 to 0.17) (Figure 2B).

Figure 2.

Figure 2.

The Effects of Probiotics on Probing Pocket Depth (PPD): Forest Plot (A) and Funnel Plot (B) Detailing Effect Size (ES) and 95% CIs

The Impact of Probiotics on Plaque Index

According to the analysis conducted by ESs, integrating data from 8 studies including 8 datasets has revealed a lack of significant effect of supplementation with probiotics on PI (ES: 0.0; 95% CI: −0.14 to 0.15; P = .97) (Figure 3A). Moreover, a notable level of heterogeneity between studies was observed (I2 = 84.9%, P-heterogeneity < .001). Subgroup analyses were conducted to identify the trustworthy source of the heterogeneity; it was found that the sample size is a significant heterogeneity factor (>1000 people vs <1000 people). No statistically significant difference was observed upon excluding a single study during a sensitivity analysis. Subgroup analyses were conducted to examine the impact of intervention duration, sample size of the included studies, and number of included studies. However, no statistically significant findings were seen across these subgroup analyses (Table 3). Funnel plots showed no asymmetry (Figure 3B), confirmed by Egger’s and Begg’s tests (P = .92 and P > .99).

Figure 3.

Figure 3.

The Effects of Probiotics on Plaque Index (PI): Forest Plot (A) and Funnel Plot (B) Detailing Effect Size (ES) and 95% CIs

Table 3.

Subgroup Analyses for the Effects of Probiotics on Periodontitis Outcomes

Effect size (ES) number ES (95% CI) a P-within b I 2(%) c P-heterogeneity d
Effect of probiotics on probing pocket depth
Overall 24 −0.03 (−0.22, 0.16) .77 97.1 <.001
Duration
≤8 6 0.21 (−0.03, 0.46) .09 89.9 <.001
8–16 7 0.11 (−0.14, 0.36) .39 87.5 <.001
>16 9 −0.14 (−0.53, 0.25) .49 98.4 <.001
NR 2 −0.43 (−0.71, −0.15) .03 62.7 .10
Number of included studies
≤10 10 −0.01 (−0.34, 0.32) .95 91.8 <.001
>10 14 −0.04 (−0.30, 0.22) .73 98.1 <.001
Sample size
≤500 14 −0.15 (−0.52, 0.22) .43 96.7 <.001
>500 10 0.14 (−0.09, 0.37) .23 97.1 <.001
Effect of probiotics on plaque index
Overall 8 −011 (−0.27, 0.05) .16 87.6 <.001
Duration
≤8 5 0.11 (−0.08, 0.30) .26 65.6 .02
>8 3 −0.34 (−0.69, 0.01) .19 89.4 <.001
Number of included studies
<10 2 −0.37 (−0.83, 0.09) .11 88.3 <.001
≥10 6 0.02 (−0.25, 0.28) .90 89.2 <.001
Sample size
<1000 4 −0.13 (−0.30, 0.04) .13 89.6 <.001
≥1000 4 −0.14 (−0.55, 0.27) .50 88.5 <.001
Effect of probiotics on clinical attachment level
Overall 14 0.16 (−0.04, 0.36) .11 94.4 <.001
Duration
≤16 7 0.15 (−0.03, 0.33) .09 87.5 <.001
>16 7 0.23 (−0.19, 0.64) .09 96.3 <.001
Number of included studies
≤10 4 0.10 (−0.29, 0.49) .60 88.6 <.001
>10 10 0.17 (−0.06, 0.41) .14 95.4 <.001
Sample size
≤1000 11 0.15 (−0.09, 0.39) .22 95.3 <.001
>1000 3 0.23 (−0.07, 0.54) .13 85.4 .001
a

Confidence interval (CI) of analysis.

b

The P-value related confidence interval of analysis for determining significance.

c

I 2 test for detecting heterogeneity.

d

Determining heterogeneity using P-value of test.

Effect of Probiotics on Clinical Attachment Level

Based on the investigation completed by ESs, the combination of data from 10 studies with 14 datasets has shown no evidence of significant effects related to the supplementation of probiotics and CAL (ES: 0.16; 95% CI: −0.04 to 0.36; P = .11) (Figure 4A). Also, based on the results, it was concluded that the obtained heterogeneity was significant. However, the source of the heterogeneity was not identified based on the subgroup analyses (I2 = 94.4%, P-heterogeneity < .001). The statistical significance of the influence of probiotics on CAL was found to be altered following a sensitivity analysis that excluded the studies conducted by J. Li (c) (2023) (ES: −0.52; 95% CI: −0.75 to −0.28) and R. Martin-Cabezas (c) (2016) (ES: −0.42; 95% CI: −0.68 to −0.16). Subgroup analyses were performed to investigate the effects of intervention duration, sample size, and the number of included studies in each meta-analysis. Nevertheless, none of these subgroup analyses yielded statistically significant results. A nonsignificant small-study effect was detected using Egger’s (P = .65) and Begg’s (P = .54) tests. Visual inspection of the funnel plot revealed an uneven distribution of meta-analyses. Also, the trim-and-fill analysis was performed with 2 imputed studies, and the results still did not show significant effects (ES: 0.05; 95% CI: −0.18 to 0.30) (Figure 4B).

Figure 4.

Figure 4.

The Effects of Probiotics on Clinical Attachment Level (CAL): Forest Plot (A) and Funnel Plot (B) Detailing Effect Size (ES) and 95% CIs

Effect of Probiotics on Bleeding on Probing

According to the results, the analysis based on standard mean differences (SMDs) for 4 studies did not demonstrate a significant effect of probiotic supplementation on BOP (ES: 0.04; 95% CI: −0.44 to 0.53; P = .86) (Figure 5A). Also, according to the results, the obtained heterogeneity was significant (I2 = 91.7%, P-heterogeneity < .001). Moreover, based on the sensitivity analysis results, none of the studies alone changed the overall result. However, the analysis performed based on weighted mean differences (WMDs) on 3 studies revealed a considerable reduction in BOP (ES: −8.20; 95% CI: −15.10 to −1.31; P = .02) (Figure 5B). In addition, as per the results, the obtained heterogeneity was significant (I2 = 82.8%, P-heterogeneity = .003).

Figure 5.

Figure 5.

Forest Plot of the Effects of Probiotics on Bleeding on Probing (BOP), Analyzed Based on Standardized Mean Difference (SMD) (A) and Weighted Mean Difference (WMD) (B)

The Impact of Probiotics on Gingival Index

The compilation of the data from 4 articles has demonstrated that there was no indication of significant impacts on GI related to the supplementation of probiotics (ES: −0.30; 95% CI: −0.81 to 0.21; P = .25) (Figure 6A). Also, based on the results, the heterogeneity was significant (I2 = 92.8%, P-heterogeneity < .001). The statistical significance of the influence of probiotics on GI was found to be altered following a sensitivity analysis that excluded the study conducted by Z. Gheisary (e) (2022) (ES: 0.37; 95% CI: 0.08 to 0.67).

Figure 6.

Figure 6.

Forest Plots of the Effects of Probiotics on Gingival Index (GI) (A) and PDD Reduction in Medium Pocket (B) Detailing Effect Size (ES) and 95% CIs

Effect of Probiotics on PDD Reduction in Medium and Deep Pockets

Combination of the data from 4 articles showed no evidence of significant effects of supplementation of probiotics on PDD reduction in medium pockets (ES: −0.10; 95% CI: −0.36 to 0.16; P = .44) (Figure 6B) or in deep pockets (ES: −0.28; 95% CI: −0.84 to 0.29; P = .33) (Figure 7). Also, the results indicated that heterogeneity was significant for PPD reduction in medium pockets (I2 = 92.4%, P-heterogeneity < .001) and in deep pockets (I2 = 97.8%, P-heterogeneity < .001). The findings of the sensitivity analysis showed that elimination of the results for the Donos et al (b) (2020) study on PPD reduction in medium pockets, and of the results for the Donos et al (c) (2020) study on PPD reduction in deep pockets, had a significant effect on the overall results.

Figure 7.

Figure 7.

Forest Plot of the Effects of Probiotics on PDD Reduction in Depth Pocket Detailing Effect Size (ES) and 95% CIs

DISCUSSION

The results of the present study indicated that the supplementation of probiotics resulted in a statistically significant decrease in BOP with WMD analysis. In addition, the findings showed a statistical significance in the CAL outcome following a sensitivity analysis. There was no statistically significant impact observed on other outcomes under investigation.

Several studies have explored the possible benefits of probiotics in enhancing periodontal health. There are multiple ways by which probiotics may exert their benefits. Probiotics can change the makeup of the oral microbiota by encouraging the growth of good bacteria and stopping the growth of harmful bacteria. This change could alter the microbial balance beneficially. This would decrease the total number of bacteria and make it harder for periodontal pathogens to spread.28 In addition, probiotics can engage with the immune system, facilitating an anti-inflammatory reaction and boosting the host’s immunological defense against periodontal infections. The stimulation of anti-inflammatory cytokine synthesis and the inhibition of pro-inflammatory cytokine release can reduce inflammation in the periodontal tissues.55 For example, it has been shown that L. reuteri exhibits an anti-inflammatory action against periodontal pathogens, including Aggregibacter actinomycetemcomitans, Porphyromonas gingivalis, F. nucleatum, and Prevotella intermedia.56 According to the findings of Haukioja et al, the coaggregation of Bifidobacterium with F. nucleatum resulted in a decrease in the number of binding sites available for periodontopathogens in the biofilm.57 Furthermore, probiotics can produce antimicrobial compounds, including bacteriocins, hydrogen peroxide, and short-chain fatty acids. Each of these substances can directly limit the growth and activity of periodontal infections, therefore playing a role in preserving periodontal health.58 Furthermore, other mechanisms, including competition for binding sites, suppression of pathogen adhesion, enhancement of the epithelial barrier, and the synthesis of antioxidants that neutralize the effects of plaque minerals, have been suggested as potential explanations for the observed therapeutic benefits of probiotics.58–60

Based on the findings, it is evident that using WMD to convey outcomes in relation to BOP yielded a statistically significant result. As previously discussed, probiotics can modulate the immune system by reducing inflammatory cytokines and increasing anti-inflammatory ones. This activity helps control the severity of the inflammatory response and maintains oral tissue homeostasis, ultimately contributing to the management of bleeding. Additionally, certain probiotic strains produce antimicrobial substances such as bacteriocins, hydrogen peroxide, and short-chain fatty acids. These compounds directly inhibit the growth and virulence of periodontal pathogens. By decreasing the viability and colonization of harmful bacteria, these antimicrobial actions reduce the overall inflammatory burden and associated bleeding.61,62 Furthermore, probiotics may enhance the expression of proteins like zonula occludens-1 (ZO-1) and occludin in epithelial cells, which are essential for maintaining tight junction integrity. Some probiotic strains also stimulate fibroblast activity and promote collagen synthesis, crucial for the repair and maintenance of periodontal tissues. Improved tissue integrity can prevent inflammatory infiltration and reduce symptoms such as bleeding on probing.63–65 An additional point to consider is the role of prebiotics. Prebiotics, which include non-digestible food components like inulin and fructooligosaccharides, support the growth and activity of beneficial microorganisms, including probiotics. In the context of periodontal health, prebiotics enhance the survival and colonization of probiotic bacteria in the oral cavity by providing a nutrient source. This support boosts the beneficial effects of probiotics on periodontal health. Moreover, prebiotics may modify the local environment to favor health-associated species over pathogenic bacteria, thereby indirectly reducing periodontal inflammation and improving symptoms like bleeding on probing.17,66,67

However, the umbrella meta-analysis of studies that utilized SMD to express their results did not yield a statistically significant outcome. As is often understood, when the mean difference values for a specific outcome obtained from various randomized controlled trials are measured using the same unit, such as a consistent rating instrument, they can be combined in a meta-analysis to get a summary estimate referred to as mean difference (MD). The pooled mean difference from separate RCTs is sometimes referred to as the WMD, due to the use of precision weights. However, in certain instances, disparate research uses distinct rating tools to assess an identical outcome, resulting in variations in the units of measurement utilized to quantify the target variable across these investigations. Pooling the mean differences from various RCTs is not feasible in such instances. Nevertheless, it is possible to calculate the SMD by dividing the mean differences by their corresponding standard deviations (SDs).68 Another potential factor contributing to the significance of the findings in studies utilizing SMD as a measure of effect magnitude is the sample size of the studies. In relation to the analysis conducted using the SMD approach, there have been 4 meta-analytical investigations, wherein the outcomes of 2 studies demonstrated a statistically significant increase, while 1 study indicated a statistically significant decrease. The findings of Gunner et al’s study54 demonstrated a notable reduction, as evidenced by the analysis of 50 clinical trial studies involving a total of 3247 patients. In comparison, Hardan et al’s study42 and Gheisary et al’s study43 examined the outcomes of 1089 and 2175 patients, respectively. These results suggested that studies with larger sample sizes may contribute to a more meaningful understanding of the subject matter.

Concerning the PPD outcome, the findings indicated no statistically significant effect associated with probiotic supplementation. Upon investigating the specifics of the datasets examined in relation to this outcome, it became apparent that the datasets demonstrated a noteworthy decrease (as opposed to those exhibiting a significant increase or nonsignificant findings) tended to have longer durations of supplementation.37,39,49 This inference was supported by the observation that the results consistently indicated a significant decrease as the duration of the studies increased. Furthermore, a similar factor contributing to the observed trend was the sample size of the datasets. Specifically, the datasets demonstrating a significant decrease exhibited a comparatively higher sample size37,46,54 compared with the datasets indicating a significant increase, similar to the previously mentioned findings. In addition, the study conducted by Gunner et al54 suggests that the utilization of high doses can be beneficial and devoid of adverse effects, contingent upon the dosage and outcome.

The results demonstrated that the intake of probiotics did not have a significant influence on CAL. However, following the sensitivity analysis, it was revealed that the overall result became significant by removing the articles of Li et al (c) (2023)37 and Martin-Cabezas et al (c) (2016).53 We assessed publication bias using both a funnel plot and Egger’s regression test, methods renowned for their efficacy in detecting asymmetry and bias within meta-analyses. Upon visual inspection, the funnel plot demonstrated observed asymmetry. However, Begg’s and Egger’s tests yielded a P-value indicating no significant evidence of publication bias. Consequently, we conducted a trim-and-fill analysis to further investigate this aspect. The potential for publication bias suggests that studies yielding significant findings might be disproportionately represented in the literature, possibly leading to inflated effect sizes. This issue is particularly critical for the outcome that attained statistical significance after the sensitivity analysis. Therefore, while the results from the sensitivity analysis indicated a significant effect, they should be interpreted with caution, given the potential presence of publication bias. One of the probable explanations relates to the characteristics of the studied studies: the number of meta-analyses entered for this outcome in the Li et al (c) (2023) study was 10, which is smaller than for other studies. Also, the average sample size of the Martin-Cabezas et al (c) (2016) study was 130 participants for this outcome, which is less than in other studies and could lead to the general conclusion that it was non-significant. Finally, it should be noted that, considering that most of the datasets included in the analysis showed a significant increase while the overall result was not significant, it seems that additional studies are needed in the topic of this outcome.

The findings indicated that datasets with a higher mean duration of intervention showed a noticeable decrease in PI.37 Conversely, datasets featuring a shorter duration of intervention demonstrated a substantial increase or an inconsequential outcome. Consequently, an increase in the duration of supplementation is likely associated with a significant reduction in PI. The lack of a substantial number of meta-analyses included in the analysis may account for the lack of meaningful overall results about the 3 outcomes: GI, reduction in PPD in moderate pockets, and reduction in PPD in deep pockets. Consequently, further investigations are warranted to advance the understanding of these 3 outcomes. Another important point is that the analysis of the methodologies employed by the included meta-analyses revealed both convergences and divergences in approaches to study selection, data analysis, and bias assessment. Variations in the statistical methods used and the criteria for study inclusion/exclusion were not observed. This review underscores the importance of methodological consistency in deriving reliable conclusions from aggregate data.

STRENGTH AND LIMITATION

Based on the searches, the present study represents the first umbrella meta-analysis investigation, focusing on the impact of probiotic supplements on treatment results among individuals diagnosed with periodontitis. This study’s objective was to comprehensively examine all relevant outcomes and, whenever feasible, conduct subgroup analysis. One of the limitations and drawbacks inherent in our investigation was the limited number of studies available for some outcomes. Consequently, this limitation compromised the precision of the final findings, potentially contributing to the lack of statistical significance observed in some outcomes. Additionally, the study was limited by a high degree of heterogeneity, and regrettably, the sources of the heterogeneity have not been identified through subgroup analysis. In summary, further studies are required to address this gap in the existing literature.

CONCLUSION

In summary, the administration of probiotics has a notable impact on reducing BOP. It increases the CAL after sensitivity analysis, thus offering potential benefits in the therapeutic management of patients. No statistically significant findings were seen. However, extending the duration of the supplement may lead to the intended consequence in the context of outcomes such as CAL and PI, albeit requiring more investigation through other research.

Supplementary Material

nuae190_Supplementary_Data

Contributor Information

Junfeng Tan, Department of Orthopedics, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, China.

Dan Zhang, Department of the Operating Room, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, China.

Li Cheng, Department of the Operating Room, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, China.

Ning Liu, Department of Plastic Surgery, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, China.

Mehrdad Jamali, Student Research Committee, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran; Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.

Helen Jamloo, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.

Rosana Farjaminejad, School of Health and Psychological Sciences, Department of Health Services Research and Management, University of London, London WC1E 7HU, United Kingdom.

Changjiang Lei, Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, China.

Ahmad Saedisomeolia, College of Health Sciences, Education Centre of Australia, Parramatta, NSW 2150, Australia; School of Human Nutrition, McGill University, Sainte Anne de Bellevue, Quebec H9X 3V9, Canada.

Abdolreza Jamilian, City of London Dental School, University of Bolton, London BL11NE, United Kingdom; Orthodontic Department, Dental School, Tehran Medical Sciences, Islamic Azad University, Tehran 19395/1495, Iran.

Author Contributions

J.T.: drafting of the manuscript, and study concept and design; D.Z.: drafting of the manuscript, and study concept and design; L.C.: drafting of the manuscript, and study concept and design; N.L.: drafting of the manuscript, and study concept and design; M.J.: interpretation of data, critical revision of the manuscript for important intellectual content, acquisition of data; and drafting of the manuscript; H.J.: critical revision of the manuscript for important intellectual content; R.F.: study concept and design, data analysis, acquisition of data, and drafting of the manuscript; C.L.: critical revision of the manuscript for important intellectual content, and study supervision; A.S.: critical revision of the manuscript for important intellectual content, and study supervision; A.J.: critical revision of the manuscript for important intellectual content, and study supervision.

Supplementary Material

Supplementary Material is available at Nutrition Reviews online.

Funding

Funding for this study was provided by the Hubei province top medical youth talent program.

Conflict of Interest

None declared.

Data Availability

Data is available on reasonable request.

References

  • 1. Könönen E, Gursoy M, Gursoy U.  Periodontitis: a multifaceted disease of tooth-supporting tissues. JCM. 2019;8:1135. 10.3390/jcm8081135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Morales A, Gandolfo A, Bravo J, et al.  Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 9-month follow-up. J Appl Oral Sci. 2018;26:e20170075. 10.1590/1678-7757-2017-0075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Pihlstrom BL, Michalowicz BS, Johnson NW.  Periodontal diseases. Lancet. 2005;366:1809–1820. 10.1016/s0140-6736(05)67728-8 [DOI] [PubMed] [Google Scholar]
  • 4. Gasner NS, Schure RS.  Periodontal Disease. StatPearls; 2023. [PubMed] [Google Scholar]
  • 5. Laudenbach JM, Simon Z.  Common dental and periodontal diseases: evaluation and management. Med Clin North Am. 2014;98:1239–1260. 10.1016/j.mcna.2014.08.002 [DOI] [PubMed] [Google Scholar]
  • 6. Williams RC.  Periodontal disease. N Engl J Med. 1990;322:373–382. 10.1056/nejm199002083220606 [DOI] [PubMed] [Google Scholar]
  • 7. Montero E, Iniesta M, Rodrigo M, et al.  Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: a randomized controlled clinical trial. J Clin Periodontol. 2017;44:708–716. 10.1111/jcpe.12752 [DOI] [PubMed] [Google Scholar]
  • 8. Salari N, Darvishi N, Heydari M, Bokaee S, Darvishi F, Mohammadi M.  Global prevalence of cleft palate, cleft lip and cleft palate and lip: a comprehensive systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2022;123:110–120. 10.1016/j.jormas.2021.05.008 [DOI] [PubMed] [Google Scholar]
  • 9. Nazir MA.  Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11:72–80. [PMC free article] [PubMed] [Google Scholar]
  • 10. Curtis MA, Diaz PI, Van Dyke TE.  The role of the microbiota in periodontal disease. Periodontol 2000. 2020;83:14–25. 10.1111/prd.12296 [DOI] [PubMed] [Google Scholar]
  • 11. Mohanty R, Asopa SJ, Joseph MD, et al.  Red complex: polymicrobial conglomerate in oral flora: a review. J Family Med Prim Care. 2019;8:3480–3486. 10.4103/jfmpc.jfmpc_759_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Kinane DF, Stathopoulou PG, Papapanou PN.  Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. 10.1038/nrdp.2017.38 [DOI] [PubMed] [Google Scholar]
  • 13. Abusleme L, Dupuy AK, Dutzan N, et al.  The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013;7:1016–1025. 10.1038/ismej.2012.174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Nguyen T, Brody H, Radaic A, Kapila Y.  Probiotics for periodontal health—current molecular findings. Periodontol 2000. 2021;87:254–267. 10.1111/prd.12382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lamont RJ, Koo H, Hajishengallis G.  The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16:745–759. 10.1038/s41579-018-0089-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. American Academy of Periodontology. Comprehensive periodontal therapy: a statement by the American Academy of Periodontology. J Periodontol. 2011;82:943–949. 10.1902/jop.2011.117001 [DOI] [PubMed] [Google Scholar]
  • 17. Seminario-Amez M, López-López J, Estrugo-Devesa A, Ayuso-Montero R, Jané-Salas E.  Probiotics and oral health: a systematic review. Med Oral Patol Oral Cir Bucal. 2017;22:e282–e288. 10.4317/medoral.21494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hung HC, Douglass CW.  Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol. 2002;29:975–986. 10.1034/j.1600-051x.2002.291102.x [DOI] [PubMed] [Google Scholar]
  • 19. Saini K, Minj J.  Multifunctional aspects of probiotics and prebiotics in health management: an overview. In: Dairy Processing: Advanced Research to Applications. Springer Singapore; 2020;119–131. [Google Scholar]
  • 20. Palai S, Derecho CMP, Kesh SS, Egbuna C, Onyeike PC.  Prebiotics, probiotics, synbiotics and its importance in the management of diseases. In: Functional Foods and Nutraceuticals: Bioactive Components, Formulations and Innovations. Springer International Publishing; 2020;173–196. [Google Scholar]
  • 21. McFarland LV, Surawicz CM, Greenberg RN, et al.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913–1918. [PubMed] [Google Scholar]
  • 22. Rondanelli M, Faliva MA, Perna S, Giacosa A, Peroni G, Castellazzi AM.  Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes. 2017;8:521–543. 10.1080/19490976.2017.1345414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Rodgers B, Kirley K, Mounsey A.  PURLs: prescribing an antibiotic? Pair it with probiotics. J Fam Pract. 2013;62:148–150. [PMC free article] [PubMed] [Google Scholar]
  • 24. Caglar E, Cildir SK, Ergeneli S, Sandalli N, Twetman S.  Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand. 2006;64:314–318. 10.1080/00016350600801709 [DOI] [PubMed] [Google Scholar]
  • 25. Pelekos G, Ho SN, Acharya A, Leung WK, McGrath C.  A double-blind, paralleled-arm, placebo-controlled and randomized clinical trial of the effectiveness of probiotics as an adjunct in periodontal care. J Clin Periodontol. 2019;46:1217–1227. 10.1111/jcpe.13191 [DOI] [PubMed] [Google Scholar]
  • 26. Tekce M, Ince G, Gursoy H, et al.  Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J Clin Periodontol. 2015;42:363–372. 10.1111/jcpe.12387 [DOI] [PubMed] [Google Scholar]
  • 27. Teughels W, Van Essche M, Sliepen I, Quirynen M.  Probiotics and oral healthcare. Periodontol 2000. 2008;48:111–147. [DOI] [PubMed] [Google Scholar]
  • 28. Gupta G.  Probiotics and periodontal health. J Med Life. 2011;4:387–394. [PMC free article] [PubMed] [Google Scholar]
  • 29. Vives-Soler A, Chimenos-Küstner E.  Effect of probiotics as a complement to non-surgical periodontal therapy in chronic periodontitis: a systematic review. Med Oral Patol Oral Cir Bucal. 2020;25:e161–e167. 10.4317/medoral.23147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Akram Z, Shafqat SS, Aati S, Kujan O, Fawzy A.  Clinical efficacy of probiotics in the treatment of gingivitis: a systematic review and meta-analysis. Aust Dent J. 2020;65:12–20. 10.1111/adj.12733 [DOI] [PubMed] [Google Scholar]
  • 31. Yanine N, Araya I, Brignardello-Petersen R, et al.  Effects of probiotics in periodontal diseases: a systematic review. Clin Oral Investig. 2013;17:1627–1634. 10.1007/s00784-013-0990-7 [DOI] [PubMed] [Google Scholar]
  • 32. Moher D, Shamseer L, Clarke M, et al. ; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Shea BJ, Reeves BC, Wells G, et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. 10.1136/bmj.j4008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Higgins JP, Thomas J, Chandler J, et al.  Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Egger M, Davey Smith G, Schneider M, Minder C.  Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. 10.1136/bmj.315.7109.629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Begg CB, Mazumdar M.  Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. [PubMed] [Google Scholar]
  • 37. Li J, Zhao G, Zhang HM, Zhu FF.  Probiotic adjuvant treatment in combination with scaling and root planing in chronic periodontitis: a systematic review and meta-analysis. Benef Microbes. 2023;14:95–108. 10.3920/bm2022.0056 [DOI] [PubMed] [Google Scholar]
  • 38. Sayardoust S, Johansson A, Jönsson D.  Do probiotics cause a shift in the microbiota of dental implants—a systematic review and meta-analysis. Front Cell Infect Microbiol. 2022;12:823985. 10.3389/fcimb.2022.823985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Ng E, Tay JRH, Saffari SE, Lim LP, Chung KM, Ong MMA.  Adjunctive probiotics after periodontal debridement versus placebo: a systematic review and meta-analysis. Acta Odontol Scand. 2022;80:81–90. 10.1080/00016357.2021.1942193 [DOI] [PubMed] [Google Scholar]
  • 40. Liu J, Liu Z, Huang J, Tao R.  Effect of probiotics on gingival inflammation and oral microbiota: a meta-analysis. Oral Dis. 2022;28:1058–1067. 10.1111/odi.13861 [DOI] [PubMed] [Google Scholar]
  • 41. Huang N, Li J, Qiao X, et al.  Efficacy of probiotics in the management of halitosis: a systematic review and meta-analysis. BMJ Open. 2022;12:e060753. 10.1136/bmjopen-2022-060753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Hardan L, Bourgi R, Cuevas-Suárez CE, et al.  The use of probiotics as adjuvant therapy of periodontal treatment: a systematic review and meta-analysis of clinical trials. Pharmaceutics. 2022;14:1017. 10.3390/pharmaceutics14051017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Gheisary Z, Mahmood R, Harri Shivanantham A, et al.  The clinical, microbiological, and immunological effects of probiotic supplementation on prevention and treatment of periodontal diseases: a systematic review and meta-analysis. Nutrients. 2022;14:1036. 10.3390/nu14051036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Sang-Ngoen T, Czumbel LM, Sadaeng W, et al.  Orally administered probiotics decrease Aggregatibacter actinomycetemcomitans but not other periodontal pathogenic bacteria counts in the oral cavity: a systematic review and meta-analysis. Front Pharmacol. 2021;12:682656. 10.3389/fphar.2021.682656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Mishra S, Misra SR, Panda S, et al.  Role of probiotics in adjunct to non-surgical periodontal therapy in patients with chronic periodontitis: a systematic review and meta-analysis. J Biol Regul Homeost Agents. 2021;35:67–78. 10.23812/21-2supp1-6 [DOI] [PubMed] [Google Scholar]
  • 46. Hu D, Zhong T, Dai Q.  Clinical efficacy of probiotics as an adjunctive therapy to scaling and root planning in the management of periodontitis: a systematic review and meta-analysis of randomized controlled trails. J Evid Based Dent Pract. 2021;21:101547. 10.1016/j.jebdp.2021.101547 [DOI] [PubMed] [Google Scholar]
  • 47. Zhao R, Hu H, Wang Y, Lai W, Jian F.  Efficacy of probiotics as adjunctive therapy to nonsurgical treatment of peri-implant mucositis: a systematic review and meta-analysis. Front Pharmacol. 2020;11:541752. 10.3389/fphar.2020.541752 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Song D, Liu XR.  Role of probiotics containing Lactobacillus reuteri in adjunct to scaling and root planing for management of patients with chronic periodontitis: a meta-analysis. Eur Rev Med Pharmacol Sci. 2020;24:4495–4505. 10.26355/eurrev_202004_21032 [DOI] [PubMed] [Google Scholar]
  • 49. Ho SN, Acharya A, Sidharthan S, et al.  A systematic review and meta-analysis of clinical, immunological, and microbiological shift in periodontitis after nonsurgical periodontal therapy with adjunctive use of probiotics. J Evid Based Dent Pract. 2020;20:101397. 10.1016/j.jebdp.2020.101397 [DOI] [PubMed] [Google Scholar]
  • 50. Donos N, Calciolari E, Brusselaers N, Goldoni M, Bostanci N, Belibasakis GN.  The adjunctive use of host modulators in non-surgical periodontal therapy. A systematic review of randomized, placebo-controlled clinical studies. J Clin Periodontol. 2020;47(suppl 22):199–238. 10.1111/jcpe.13232 [DOI] [PubMed] [Google Scholar]
  • 51. Nadelman P, Magno MB, Masterson D, da Cruz AG, Maia LC.  Are dairy products containing probiotics beneficial for oral health? A systematic review and meta-analysis. Clin Oral Investig. 2018;22:2763–2785. 10.1007/s00784-018-2682-9 [DOI] [PubMed] [Google Scholar]
  • 52. Ikram S, Hassan N, Raffat MA, Mirza S, Akram Z.  Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis. J Investig Clin Dent. 2018;9:e12338. 10.1111/jicd.12338 [DOI] [PubMed] [Google Scholar]
  • 53. Martin-Cabezas R, Davideau JL, Tenenbaum H, Huck O.  Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016;43:520–530. 10.1111/jcpe.12545 [DOI] [PubMed] [Google Scholar]
  • 54. Gruner D, Paris S, Schwendicke F.  Probiotics for managing caries and periodontitis: systematic review and meta-analysis. J Dent. 2016;48:16–25. 10.1016/j.jdent.2016.03.002 [DOI] [PubMed] [Google Scholar]
  • 55. Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC.  Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 2023;12:184. 10.3390/cells12010184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Baca-Castañón ML, De la Garza-Ramos MA, Alcázar-Pizaña AG, et al.  Antimicrobial effect of Lactobacillus reuteri on cariogenic bacteria Streptococcus gordonii, Streptococcus mutans, and periodontal diseases Actinomyces naeslundii and Tannerella forsythia. Probiotics Antimicrob Proteins. 2015;7:1–8. 10.1007/s12602-014-9178-y [DOI] [PubMed] [Google Scholar]
  • 57. Haukioja A, Yli-Knuuttila H, Loimaranta V, et al.  Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol. 2006;21:326–332. 10.1111/j.1399-302X.2006.00299.x [DOI] [PubMed] [Google Scholar]
  • 58. Lee Y, Yoon Y, Choi KH.  Probiotics-mediated bioconversion and periodontitis. Food Sci Anim Resour. 2021;41:905–922. 10.5851/kosfa.2021.e57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Kaźmierczyk-Winciorek M, Nędzi-Góra M, Słotwińska SM.  The immunomodulating role of probiotics in the prevention and treatment of oral diseases. Cent Eur J Immunol. 2021;46:99–104. 10.5114/ceji.2021.104412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A.  Probiotic mechanisms of action. Ann Nutr Metab. 2012;61:160–174. 10.1159/000342079 [DOI] [PubMed] [Google Scholar]
  • 61. Haukioja A.  Probiotics and oral health. Eur J Dent. 2010;4:348–355. [PMC free article] [PubMed] [Google Scholar]
  • 62. Meurman JH, Stamatova I.  Probiotics: contributions to oral health. Oral Dis. 2007;13:443–451. 10.1111/j.1601-0825.2007.01386.x [DOI] [PubMed] [Google Scholar]
  • 63. Jones RM, Mercante JW, Neish AS.  Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. Curr Med Chem. 2012;19:1519–1529. 10.2174/092986712799828283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Anderson RC, Cookson AL, McNabb WC, et al.  Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 2010;10:316. 10.1186/1471-2180-10-316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Doron S, Gorbach S.  Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti-Infect Ther.  2006;4:261–275. 10.1586/14787210.4.2.261 [DOI] [PubMed] [Google Scholar]
  • 66. Hojo K, Nagaoka S, Ohshima T, Maeda N.  Bacterial interactions in dental biofilm development. J Dent Res. 2009;88:982–990. 10.1177/0022034509346811 [DOI] [PubMed] [Google Scholar]
  • 67. Roberfroid M.  Prebiotics: the concept revisited. J Nutr. 2007;137:830s–837s. 10.1093/jn/137.3.830S [DOI] [PubMed] [Google Scholar]
  • 68. Andrade C.  Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020;81:20f13681. 10.4088/JCP.20f13681 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

nuae190_Supplementary_Data

Data Availability Statement

Data is available on reasonable request.


Articles from Nutrition Reviews are provided here courtesy of Oxford University Press

RESOURCES